Aldosterone: New Insights and Emerging Perspectives for Cardiologists
This educational series explores the role of aldosterone in cardio-renal-metabolic (CRM) conditions, with a focus on emerging therapies and interdisciplinary care. It highlights aldosterone’s contribution to cardiovascular and renal damage and examines the clinical potential of aldosterone synthase inhibitors (ASIs).
21 July 2025
virtual
Module 2:
Revisiting Aldosterone in Chronic Kidney Disease: Implications for Cardiovascular Care
Speaker: Prof. Christoph Wanner
Würzburg, Germany
Lectures
Dr. Jennifer Green
Durham, USA
Module 1:
The Role of Aldosterone in Cardio-Renal-Metabolic Syndrome: Insights into its Development and Progression
Watch LectureProf. Christoph Wanner
Würzburg, Germany
Module 2:
Revisiting Aldosterone in Chronic Kidney Disease: Implications for Cardiovascular Care
Current LectureDr. Beatriz Fernández-Fernández
Madrid, Spain
Module 3:
New Perspectives for improving Cardio-Renal Outcomes in Chronic Kidney Disease
Watch LectureInsights, Reflections and Discussion Part 2
Prof. Christoph Wanner, Prof. Francesco Cosentino
Insights, Reflections and Discussion Part 3
Dr. Beatriz Fernández-Fernández, Dr. Stephen Greene
Downloads
Literature
Yang J, et al. J Endocrinol. 2023;259(1):e220249.doi: 10.1530/JOE-22-0249
Verma A, et al. Eur Heart J. 2022;43(38):3781-3791.doi: 10.1093/eurheartj/ehac352
Tuttle KR, et al. Lancet. 2024;403(10424):379-390.doi: 10.1016/S0140-6736(23)02408-X